Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26652 | 249 | 31.5 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1102 | 2 | PACLITAXEL//TAXANES//EPOTHILONES | 9807 |
26652 | 1 | NOSCAPINE//NOSCAPINOIDS//AMINO NOSCAPINE | 249 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NOSCAPINE | authKW | 6456995 | 30% | 71% | 74 |
2 | NOSCAPINOIDS | authKW | 551840 | 2% | 75% | 6 |
3 | AMINO NOSCAPINE | authKW | 367896 | 1% | 100% | 3 |
4 | 9 BROMONOSCAPINE | authKW | 245264 | 1% | 100% | 2 |
5 | ALPHA NARCOTINE | authKW | 245264 | 1% | 100% | 2 |
6 | BETA NARCOTINE | authKW | 245264 | 1% | 100% | 2 |
7 | BROMO NOSCAPINE | authKW | 245264 | 1% | 100% | 2 |
8 | BRUCEANTINOL | authKW | 245264 | 1% | 100% | 2 |
9 | EM011 | authKW | 245264 | 1% | 100% | 2 |
10 | EM012 | authKW | 245264 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1220 | 41% | 0% | 103 |
2 | Chemistry, Medicinal | 347 | 12% | 0% | 29 |
3 | Oncology | 253 | 18% | 0% | 45 |
4 | Chemistry, Multidisciplinary | 83 | 14% | 0% | 36 |
5 | BIOLOGY, MISCELLANEOUS | 78 | 0% | 0% | 1 |
6 | MEDICINE, MISCELLANEOUS | 76 | 0% | 0% | 1 |
7 | Chemistry, Analytical | 59 | 8% | 0% | 20 |
8 | Biochemical Research Methods | 21 | 4% | 0% | 10 |
9 | Biophysics | 12 | 4% | 0% | 9 |
10 | Computer Science, Interdisciplinary Applications | 10 | 2% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BR AMBEDKAR BIOMED | 231104 | 3% | 27% | 7 |
2 | AFFIIATED JIANGSU CANC HOSP | 122632 | 0% | 100% | 1 |
3 | AFLAC CAN | 122632 | 0% | 100% | 1 |
4 | DEVIS INORGAN CHEM | 122632 | 0% | 100% | 1 |
5 | GYEONGJU | 122632 | 0% | 100% | 1 |
6 | INTRAVENOUS DRUG USE DEV | 122632 | 0% | 100% | 1 |
7 | PHARM PHARMACEU SCI | 122632 | 0% | 100% | 1 |
8 | PHARMAKOL FOR ABT | 122632 | 0% | 100% | 1 |
9 | PHYIOL | 122632 | 0% | 100% | 1 |
10 | PROGRAM BIOCHEM CEL DEV BIOL | 122632 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LATIN AMERICAN JOURNAL OF PHARMACY | 29201 | 10% | 1% | 24 |
2 | PROGRESS IN MEDICINAL CHEMISTRY | 6811 | 0% | 6% | 1 |
3 | LABORATORNOE DELO | 2473 | 2% | 1% | 4 |
4 | ANTI-CANCER DRUGS | 1832 | 3% | 0% | 7 |
5 | ACTA CHIMICA ACADEMIAE SCIENTARIUM HUNGARICAE | 1460 | 1% | 1% | 2 |
6 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1270 | 2% | 0% | 4 |
7 | JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | 1103 | 2% | 0% | 4 |
8 | ARCHIV DER PHARMAZIE | 705 | 2% | 0% | 5 |
9 | BULLETIN ON NARCOTICS | 691 | 0% | 1% | 1 |
10 | ACTA PHARMACEUTICA NORDICA | 650 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOSCAPINE | 6456995 | 30% | 71% | 74 | Search NOSCAPINE | Search NOSCAPINE |
2 | NOSCAPINOIDS | 551840 | 2% | 75% | 6 | Search NOSCAPINOIDS | Search NOSCAPINOIDS |
3 | AMINO NOSCAPINE | 367896 | 1% | 100% | 3 | Search AMINO+NOSCAPINE | Search AMINO+NOSCAPINE |
4 | 9 BROMONOSCAPINE | 245264 | 1% | 100% | 2 | Search 9+BROMONOSCAPINE | Search 9+BROMONOSCAPINE |
5 | ALPHA NARCOTINE | 245264 | 1% | 100% | 2 | Search ALPHA+NARCOTINE | Search ALPHA+NARCOTINE |
6 | BETA NARCOTINE | 245264 | 1% | 100% | 2 | Search BETA+NARCOTINE | Search BETA+NARCOTINE |
7 | BROMO NOSCAPINE | 245264 | 1% | 100% | 2 | Search BROMO+NOSCAPINE | Search BROMO+NOSCAPINE |
8 | BRUCEANTINOL | 245264 | 1% | 100% | 2 | Search BRUCEANTINOL | Search BRUCEANTINOL |
9 | EM011 | 245264 | 1% | 100% | 2 | Search EM011 | Search EM011 |
10 | EM012 | 245264 | 1% | 100% | 2 | Search EM012 | Search EM012 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RIDA, PCG , LIVECCHE, D , OGDEN, A , ZHOU, J , ANEJA, R , (2015) THE NOSCAPINE CHRONICLE: A PHARMACO-HISTORIC BIOGRAPHY OF THE OPIATE ALKALOID FAMILY AND ITS CLINICAL APPLICATIONS.MEDICINAL RESEARCH REVIEWS. VOL. 35. ISSUE 5. P. 1072 -1096 | 62 | 71% | 4 |
2 | TOMAR, V , KUKRETI, S , PRAKASH, S , MADAN, J , CHANDRA, R , (2017) NOSCAPINE AND ITS ANALOGS AS CHEMOTHERAPEUTIC AGENT: CURRENT UPDATES.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 17. ISSUE 2. P. 174 -188 | 73 | 46% | 0 |
3 | MANCHUKONDA, NK , NAIK, PK , SRIDHAR, B , KANTEVARI, S , (2014) SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL BIARYL TYPE ALPHA-NOSCAPINE CONGENERS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 24. ISSUE 24. P. 5752 -5757 | 25 | 81% | 1 |
4 | MAHMOUDIAN, M , RAHIMI-MOGHADDAM, P , (2009) THE ANTI-CANCER ACTIVITY OF NOSCAPINE: A REVIEW.RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY. VOL. 4. ISSUE 1. P. 92-97 | 26 | 76% | 50 |
5 | DEBONO, A , CAPUANO, B , SCAMMELLS, PJ , (2015) PROGRESS TOWARD THE DEVELOPMENT OF NOSCAPINE AND DERIVATIVES AS ANTICANCER AGENTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 58. ISSUE 15. P. 5699 -5727 | 41 | 36% | 4 |
6 | LOPUS, M , NAIK, PK , (2015) TAKING AIM AT A DYNAMIC TARGET: NOSCAPINOIDS AS MICROTUBULE-TARGETED CANCER THERAPEUTICS.PHARMACOLOGICAL REPORTS. VOL. 67. ISSUE 1. P. 56 -62 | 23 | 62% | 5 |
7 | CHOUGULE, MB , PATEL, AR , PATLOLLA, R , JACKSON, T , SINGH, M , (2014) EPITHELIAL TRANSPORT OF NOSCAPINE ACROSS CELL MONOLAYER AND INFLUENCE OF ABSORPTION ENHANCERS ON IN VITRO PERMEATION AND BIOAVAILABILITY: IMPLICATIONS FOR INTESTINAL ABSORPTION.JOURNAL OF DRUG TARGETING. VOL. 22. ISSUE 6. P. 498 -508 | 29 | 51% | 2 |
8 | MANCHUKONDA, NK , NAIK, PK , SANTOSHI, S , LOPUS, M , JOSEPH, S , SRIDHAR, B , KANTEVARI, S , (2013) RATIONAL DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF THIRD GENERATION ALPHA-NOSCAPINE ANALOGUES AS POTENT TUBULIN BINDING ANTI-CANCER AGENTS.PLOS ONE. VOL. 8. ISSUE 10. P. - | 25 | 57% | 7 |
9 | ANEJA, R , DHIMAN, N , IDNANI, J , AWASTHI, A , ARORA, SK , CHANDRA, R , JOSHI, HC , (2007) PRECLINICAL PHARMACOKINETICS AND BIOAVAILABILITY OF NOSCAPINE, A TUBULIN-BINDING ANTICANCER AGENT.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 60. ISSUE 6. P. 831 -839 | 19 | 79% | 31 |
10 | CHANDRA, R , MADAN, J , SINGH, P , CHANDRA, A , KUMAR, P , TOMAR, V , DASS, SK , (2012) IMPLICATIONS OF NANOSCALE BASED DRUG DELIVERY SYSTEMS IN DELIVERY AND TARGETING TUBULIN BINDING AGENT, NOSCAPINE IN CANCER CELLS.CURRENT DRUG METABOLISM. VOL. 13. ISSUE 10. P. 1476-1483 | 24 | 56% | 7 |
Classes with closest relation at Level 1 |